Citation Impact
Citing Papers
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
2015 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Promoting novelty, rigor, and style in energy social science: Towards codes of practice for appropriate methods and research design
2018 Standout
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
2010 Standout
Influence of ethnicity on histological differences in non-alcoholic fatty liver disease
2009
Pathology of fatty liver disease
2007
Non‐alcoholic fatty liver disease in the Asia–Pacific region: Definitions and overview of proposed guidelines
2007
Non Alcoholic Fatty Liver: Epidemiology and Natural History
2015
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
NAFLD prevalence differs among hispanic subgroups: The multi-ethnic study of atherosclerosis
2014
Nonalcoholic Fatty Liver Disease in Latinos
2015
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
2020 Standout
Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations
2014
Burden of liver diseases in the world
2018 Standout
The Effect of PNPLA3 on Fibrosis Progression and Development of Hepatocellular Carcinoma: A Meta-analysis
2014
Nonalcoholic Fatty Liver Disease in Severely Obese Subjects
2007
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
2017 Standout
High Rates of Fructose Malabsorption Are Associated with Reduced Liver Fat in Obese African Americans
2012
Nonalcoholic Fatty Liver Disease Epidemic and Its Implications for Liver Transplantation
2013
Nonalcoholic Fatty Liver Disease: A Review and Update
2010
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
2015 Standout
A position statement on NAFLD/NASH based on the EASL 2009 special conference
2010
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
2010 Standout
New Imaging Techniques for Non-Alcoholic Steatohepatitis
2009
Nonalcoholic fatty liver disease in Asia: emerging perspectives
2016
Ethnic differences in hepatic steatosis
2008
Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality
2016
Pharmacotherapy for NASH: Current and emerging
2017
Nonalcoholic fatty liver disease
2008
NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances
2018
Correlates and Heritability of Nonalcoholic Fatty Liver Disease in a Minority Cohort
2009
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
From NAFLD in clinical practice to answers from guidelines
2013
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
2015 Standout
Sex difference in the liver of hepatocyte‐specific Pten‐deficient mice: A model of nonalcoholic steatohepatitis
2009 StandoutNobel
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Lack of Exercise Is a Major Cause of Chronic Diseases
2012 Standout
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
2010
Epidemiology and Natural History of Non-Alcoholic Steatohepatitis
2009
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
2011 Standout
Gender and racial differences in nonalcoholic fatty liver disease
2014
A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis
2010
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Estimation of the Healthy Upper Limits for Serum Alanine Aminotransferase in Asian Populations With Normal Liver Histology
2009
Liver biopsy findings from healthy potential living liver donors: Reasons for disqualification, silent diseases and correlation with liver injury tests
2008
Liver Transplantation for Nonalcoholic Steatohepatitis
2012
Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations
2016
Pathology of nonalcoholic fatty liver disease
2010
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: A review of 589 consecutive liver biopsies in a single center
2007
Global burden of liver disease: 2023 update
2023 Standout
The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
2006 Standout
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
The global NAFLD epidemic
2013 Standout
NAFLD in Asia—as common and important as in the West
2013
Nonalcoholic fatty liver disease in women with polycystic ovary syndrome
2019
Nonalcoholic Fatty Liver Disease Increases Risk of Death Among Patients With Diabetes: A Community-Based Cohort Study
2010
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Nonalcoholic fatty liver disease and the metabolic syndrome
2005
Non-alcoholic fatty liver disease (NAFLD) in the Western Cape: A descriptive anaylsis
2010
Energy Metabolism in the Liver
2014 Standout
Epidemiology and Natural History of NAFLD and NASH
2007
Ethnicity and nonalcoholic fatty liver disease
2011
Insulin Resistance: A Metabolic Pathway to Chronic Liver Disease *
2005
Nonalcoholic fatty liver disease in women with polycystic ovary syndrome
2007
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
2014
Non‐alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C‐reactive protein in Hispanics
2008
NAFLD: A multisystem disease
2015 Standout
The Prevalence and Pathobiology of Nonalcoholic Fatty Liver Disease in Patients of Different Races or Ethnicities
2016
Ethnicity and Nonalcoholic Fatty Liver Disease in an Obesity Clinic: The Impact of Triglycerides
2008
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Gliptins Suppress Inflammatory Macrophage Activation to Mitigate Inflammation, Fibrosis, Oxidative Stress, and Vascular Dysfunction in Models of Nonalcoholic Steatohepatitis and Liver Fibrosis
2017
Ethnic and Gender Differences in the Prevalence of Nonalcoholic Steatohepatitis Among Bariatric Surgery Patients
2016
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
A review of energy systems models in the UK: Prevalent usage and categorisation
2016 Standout
Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
2010
Non-alcoholic fatty liver disease (NAFLD) in different populations: A clinical and epidemiological study – sample of São José do Rio Preto
2016
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
The Three Domains structure of energy-climate transitions
2015
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
2015
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Renewable Power-to-Gas: A technological and economic review
2015 Standout
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
2014 Standout
Evaluation of blood oxidative stress‐related parameters in alcoholic liver disease and non‐alcoholic fatty liver disease
2008
Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies.
2007
The Role of Oxidative Stress and Antioxidants in Liver Diseases
2015 Standout
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
2011 StandoutNobel
Racial differences in nonalcoholic fatty liver disease in the U.S. population
2013
The role of hydrogen and fuel cells in the global energy system
2018 Standout
Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease in an Adult Population of Taiwan: Metabolic Significance of Nonalcoholic Fatty Liver Disease in Nonobese Adults
2006
The prevalence of nonalcoholic fatty liver disease in the Americas
2014
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
2017 Standout
Nonalcoholic Fatty Liver Disease
2015 Standout
A review of the technologies, economics and policy instruments for decarbonising energy-intensive manufacturing industries
2013
Works of Rose Murphy being referenced
Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease†
2005
Energy efficiency and the cost of GHG abatement: A comparison of bottom-up and hybrid models for the US
2011